Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Assets Average (2020 - 2025)

Historic Assets Average for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $1.2 billion.

  • Harmony Biosciences Holdings' Assets Average rose 2965.03% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 2965.03%. This contributed to the annual value of $905.3 million for FY2024, which is 2190.31% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Assets Average stood at $1.2 billion, which was up 2965.03% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Assets Average peaked at $1.2 billion during Q3 2025, and registered a low of $348.5 million during Q2 2021.
  • Moreover, its 5-year median value for Assets Average was $737.6 million (2023), whereas its average is $709.8 million.
  • In the last 5 years, Harmony Biosciences Holdings' Assets Average skyrocketed by 1035.78% in 2021 and then skyrocketed by 5976.69% in 2022.
  • Over the past 5 years, Harmony Biosciences Holdings' Assets Average (Quarter) stood at $412.3 million in 2021, then surged by 59.77% to $658.7 million in 2022, then increased by 20.64% to $794.6 million in 2023, then increased by 21.28% to $963.7 million in 2024, then rose by 20.18% to $1.2 billion in 2025.
  • Its Assets Average stands at $1.2 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.